Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA fast-tracks Omeros' kidney drug as company moves into Phase 3 tests
FDA fast-tracks Omeros' kidney drug as company moves into Phase 3 tests
FDA fast-tracks Omeros' kidney drug as company moves into Phase 3 tests
Submitted by
admin
on March 9, 2016 - 9:18am
Source:
Bizjournals.com
News Tags:
FDA
fast track
Omeros
OMS721
kidney disease
Headline:
FDA fast-tracks Omeros' kidney drug as company moves into Phase 3 tests
Do Not Allow Advertisers to Use My Personal information
